Technology News and Research

RSS

Saints Medical Center enters multi-faceted agreement with ZOLL

Saints Medical Center, a leading non-profit healthcare facility in the Greater Lowell area, is pleased to announce it has entered into a multi-faceted agreement with ZOLL Medical Corporation (Nasdaq: ZOLL) of Chelmsford, Mass., a leader in comprehensive hospital and EMS resuscitation solutions. This agreement includes the Saints-based EMS service working with ZOLL to collaborate on and test new product concepts and technology concepts.

7 Jan 2011

DARPA grants million dollar to IDRI to develop single dose influenza vaccine

The Infectious Disease Research Institute today announced it has received a multi-million dollar grant from the Defense Advanced Research Projects Agency, and the Army Research Office, both parts of United States Department of Defense.

7 Jan 2011

Receptos, Eli Lilly collaborate to develop molecule modulators of GPCR target

Receptos, a drug discovery and development company, announced today the establishment of a collaboration with Eli Lilly and Company to research and develop small molecule modulators of an undisclosed GPCR target.

7 Jan 2011

Amgen, Xencor collaborate to develop XmAb5871 for autoimmune disease

Amgen and Xencor, announced today that they will collaborate to develop XmAb®5871, an Fc- engineered monoclonal antibody dually targeting CD19 and CD32b. XmAb5871 is currently in late-stage preclinical development for the treatment of autoimmune diseases.

7 Jan 2011

X-BODY BioSciences, Mercator Therapeutics collaborate for multi-target cancer research

Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs, and X-BODY BioSciences, a developer of monoclonal antibody therapeutics, today announced a multi-target research collaboration.

7 Jan 2011

Ligand, Chiva Pharmaceuticals enter strategic relationship to develop multiple Ligand assets, technology

Ligand Pharmaceuticals Incorporated announced today that it has entered into a strategic relationship with Chiva Pharmaceuticals, to develop multiple Ligand assets and technology in China and potentially worldwide.

7 Jan 2011

Virdante Pharmaceuticals receives US key patent for Sialic Switch technology

Virdante Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office has granted a key patent that supports the Company's "Sialic Switch" technology for improving the anti-inflammatory activity of antibody-based drugs to treat autoimmune and inflammatory disorders.

7 Jan 2011

Isis Pharmaceuticals announces addition of two new drugs to development pipeline

Isis Pharmaceuticals, announced today that it has added two new drugs to its development pipeline, ISIS-FGFR4Rx and ISIS-STAT3Rx.

7 Jan 2011

Researchers develop simple blood test to track Alzheimer's disease

Using a new technology that relies on thousands of synthetic molecules to fish for disease-specific antibodies, researchers have developed a potential method for detecting Alzheimer's disease with a simple blood test.

6 Jan 2011

Metabolon announces publication of 'Metabolomic Distinction and Insights into the Pathogenesis of Human Primary Dilated Cardiomyopathy'

Metabolon, the leader in metabolomics, biomarker discovery and analysis, announces the publication of "Metabolomic Distinction and Insights into the Pathogenesis of Human Primary Dilated Cardiomyopathy", in the European Journal of Clinical Investigation.

6 Jan 2011

Antigenics announces name change to Agenus

Antigenics Inc. today announced that effective immediately it is changing its name to Agenus Inc. The company's stock will continue to be traded on NASDAQ under the symbol AGEN. The new name reflects the broadening of the company's product portfolio of clinical candidates beyond autologous antigen-based vaccines, as well as its commitment to actively pursuing licensing opportunities to leverage its development capabilities and expand its product portfolio.

6 Jan 2011

Scientists develop novel technology to detect immune molecules specific to Alzheimer's disease

Scientists from the Florida campus of The Scripps Research Institute, have developed a novel technology that is able to detect the presence of immune molecules specific to Alzheimer's disease in patients' blood samples. While still preliminary, the findings offer clear proof that this breakthrough technology could be used in the development of biomarkers for a range of human diseases.

6 Jan 2011

New technique to analyze and quantify changes in protein

A scientist from the Florida campus of The Scripps Research Institute has devised a new method of analyzing and quantifying changes in proteins that result from a common chemical process. The new findings could provide new insights into the effects of a highly destructive form of stress on proteins in various disease models, particularly cancer.

6 Jan 2011

Report urges Minnesotans to protect, preserve water resources

The University of Minnesota's Water Resources Center has authored a first-ever, comprehensive report designed to protect and preserve Minnesota's lakes, rivers and groundwater for the 21st century and beyond.

6 Jan 2011

InHealth awards grant to assess effects of hip replacement therapy on aging populations

The Institute for Health Technology Studies has awarded a grant of $240,000 to an international consortium of researchers, for a study that will assess the effects of hip replacement therapy on the employment and retirement decisions of older adults. Led by researchers at the Universit- Bocconi (Milan), the consortium also includes investigators at the University of York (York, UK), and the Johns Hopkins University School of Public Health (Baltimore).

6 Jan 2011

JMD publishes results of Tissue of Origin Test validation, reproducibility study

Pathwork Diagnostics, Inc., a privately held molecular diagnostics company focused on oncology, announced today that The Journal of Molecular Diagnostics has published the results of a significant Tissue of Origin Test validation and reproducibility study.

6 Jan 2011

Synageva BioPharma, to-BBB to evaluate brain drug delivery technology

Synageva BioPharma Corp. and to-BBB technologies BV, the Dutch drug brain delivery company, have entered into a research collaboration to evaluate the potential of transporting therapeutic proteins across the blood-brain barrier into the central nervous system.

6 Jan 2011

Study provides global estimate of unreported mesothelioma cases

For every four to five reported cases of mesothelioma worldwide, at least one case goes unreported, according to estimates published online January 6 ahead of print in the peer-reviewed journal Environmental Health Perspectives.

6 Jan 2011

FDA clears STI Medical Systems' ImageSense technology for use in colposcopy

STI Medical Systems, an industry leader in medical imaging systems and machine vision software, announced today that the U.S. Food and Drug Administration has given clearance to the Company's precedent-setting ImageSense technology for use in colposcopy.

6 Jan 2011

Digital reminiscence system can improve quality of life for people with mild dementia

Dementia is on the increase, but for the sake of the quality of life of sufferers and their family and friends finding ways to allow the patient to remain in their own home and to live independently is an issue that must be addressed. At the same time, enabling independent living could also reduce the economic burden.

6 Jan 2011

Technology News and Research

Saints Medical Center enters multi-faceted agreement with ZOLL

DARPA grants million dollar to IDRI to develop single dose influenza vaccine

Receptos, Eli Lilly collaborate to develop molecule modulators of GPCR target

Amgen, Xencor collaborate to develop XmAb5871 for autoimmune disease

X-BODY BioSciences, Mercator Therapeutics collaborate for multi-target cancer research

Ligand, Chiva Pharmaceuticals enter strategic relationship to develop multiple Ligand assets, technology

Virdante Pharmaceuticals receives US key patent for Sialic Switch technology

Isis Pharmaceuticals announces addition of two new drugs to development pipeline

Researchers develop simple blood test to track Alzheimer's disease

Metabolon announces publication of 'Metabolomic Distinction and Insights into the Pathogenesis of Human Primary Dilated Cardiomyopathy'

Antigenics announces name change to Agenus

Scientists develop novel technology to detect immune molecules specific to Alzheimer's disease

New technique to analyze and quantify changes in protein

Report urges Minnesotans to protect, preserve water resources

InHealth awards grant to assess effects of hip replacement therapy on aging populations

JMD publishes results of Tissue of Origin Test validation, reproducibility study

Synageva BioPharma, to-BBB to evaluate brain drug delivery technology

Study provides global estimate of unreported mesothelioma cases

FDA clears STI Medical Systems' ImageSense technology for use in colposcopy

Digital reminiscence system can improve quality of life for people with mild dementia

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News